The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
Open accessAbstract
Topical application of coal tar is one of the oldest therapies for atopic dermatitis (AD), a T helper 2 (Th2) lymphocyte-mediated skin disease associated with loss-of-function mutations in the skin barrier gene, filaggrin (FLG). Despite its longstanding clinical use and efficacy, the molecular mechanism of coal tar therapy is unknown. Using organotypic skin models with primary keratinocytes from AD patients and controls, we found that coal tar activated the aryl hydrocarbon receptor (AHR), resulting in induction of epidermal differentiation. AHR knockdown by siRNA completely abrogated this effect. Coal tar restored filaggrin expression in FLG-haploinsufficient keratinocytes to wild-type levels, and counteracted Th2 cytokine-mediated downregulation of skin barrier proteins. In AD patients, coal tar completely restored expression of major skin barrier proteins, including filaggrin. Using organotypic skin models stimulated with Th2 cytokines IL-4 and IL-13, we found coal tar to diminish spongiosis, apoptosis, and CCL26 expression, all AD hallmarks. Coal tar interfered with Th2 cytokine signaling via dephosphorylation of STAT6, most likely due to AHR-regulated activation of the NRF2 antioxidative stress pathway. The therapeutic effect of AHR activation herein described opens a new avenue to reconsider AHR as a pharmacological target and could lead to the development of mechanism-based drugs for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, coal tar has been shown to bind to AhR and to restore the expression of filaggrin, as shown by immunohistochemistry and transcriptomic analysis59.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [59]
In the citing paper
“Activation of NRF2 by AHR ligands such as coal tar abolished IL-4/IL-13–mediated inhibition of epidermal barrier proteins such as FLG and LOR (42, 56).”
From Particulate matter causes skin barrier dysfunction. (2021) · cites this paper as [56]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,629
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,100
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis‐Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,026
The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid Cells
Qiu, J., Heller, J. J., Guo, X., Chen, Z. E., Fish, K., Fu, Y., & Zhou, L. (2011) · Immunity · doi:10.1016/j.immuni.2011.11.011 · Cited by 887
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 373
Gram-scale synthesis of FICZ, a photoreactive endogenous ligand of the aryl hydrocarbon receptor
Zhang, C., Creech, K. L., Zuercher, W. J., & Willson, T. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46374-7 · Cited by 18
Rico-Leo, E. M., Lorenzo‐Martín, L. F., Román, Á., Bustelo, X. R., Merino, J. M., & Fernández‐Salguero, P. M. (2021) · Stem Cells · doi:10.1002/stem.3443 · Cited by 20
Baur, R., Gandhi, J., Marshall, N. B., Lukomska, E., Weatherly, L. M., Shane, H. L., Hu, G., & Anderson, S. E. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab111 · Cited by 18
Kim, H. B., Choi, M. G., Chung, B. Y., Um, J., Kim, J. C., Park, C. W., & Kim, H. O. (2022) · Experimental Dermatology · doi:10.1111/exd.14724 · Cited by 19
Gram-positive anaerobic cocci guard skin homeostasis by regulating host-defense mechanisms
van der Krieken, D. A., Rikken, G., Ederveen, T. H. A., Jansen, P. A. M., Rodijk‐Olthuis, D., Meesters, L. D., van Vlijmen‐Willems, I. M. J. J., van Cranenbroek, B., Molen, R. G. V. D., Schalkwijk, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106483 · Cited by 16
Self-citationAryl hydrocarbon receptor and IL-13 signaling crosstalk in human keratinocytes and atopic dermatitis
Proper, S. P., Dwyer, A. T., Appiagyei, A., Felton, J. M., Morgenstern, N. B.-B., Marlman, J. M., Kotliar, M., Barski, A., Troutman, T. D., Rothenberg, M. E., et al. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1323405 · Cited by 20
Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review
Dec, M., & Arasiewicz, H. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.135617 · Cited by 22
The Psoriasis Treatment Pipeline
Hawkes, J. E., Al-Saedy, M. A., Bouché, N., Al-Saedy, S., Drew, D. T., & Song, E. J. (2024) · Dermatologic Clinics · doi:10.1016/j.det.2024.02.006 · Cited by 17
Wei, P. Y., Hu, G.-H., Kang, H., Yao, H., Kou, W., Zhang, C., & Hong, S. (2013) · Inflammation · doi:10.1007/s10753-013-9751-7 · Cited by 17
Corneocyte proteomics: Applications to skin biology and dermatology
Rice, R. H., Durbin-Johnson, B. P., Mann, S. M., Salemi, M., Urayama, S., Rocke, D. M., Phinney, B. S., & Sundberg, J. P. (2018) · Experimental Dermatology · doi:10.1111/exd.13756 · Cited by 17
Novel therapies based on the pathophysiology of atopic dermatitis
Bieber, T. R. M. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13965 · Cited by 16
Hong, C.-H., Lin, S.-H., Clausen, B. E., & Lee, C.-H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917479117 · Cited by 17
Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis
Wei, P. Y., Hu, G., Kang, H., Yao, H., Kou, W., Liu, H., & Hong, S. L. (2013) · QJM · doi:10.1093/qjmed/hct188 · Cited by 17
Staphylococcus aureus Activates the Aryl Hydrocarbon Receptor in Human Keratinocytes
Stange, E.-L., Rademacher, F., Drerup, K. A., Heinemann, N., Möbus, L., Gläser, R., & Harder, J. (2022) · Journal of Innate Immunity · doi:10.1159/000524033 · Cited by 17
Shim, K., Park, M., Yang, W., Lee, H., Kim, S., Choo, B.-K., Chae, S., Kim, H.-K., Kim, T. S., & Kim, K.-M. (2023) · Antioxidants · doi:10.3390/antiox12061267 · Cited by 16
Xenobiotic Receptors and Their Mates in Atopic Dermatitis
Minzaghi, D., Pavel, P., & Dubrac, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174234 · Cited by 16
Zhang, L., Dong, M.-N., Deng, J., Zhang, C.-H., & Liu, M. (2022) · Bioengineered · doi:10.1080/21655979.2022.2045764 · Cited by 17
Guardians of the barrier: Microbiota engage AHR in keratinocytes to maintain skin homeostasis
Alwan, W., & Meglio, P. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.007 · Cited by 15
Targeting NRF2 to promote epithelial repair
Hiebert, P., & Werner, S. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220228 · Cited by 16
Atopic dermatitis: skin care and topical therapies
Fleischer, D. M., Udkoff, J., Borok, J. F., Friedman, A., Nicol, N. H., Bienstock, J., Lio, P., Tollefson, M. M., & Eichenfield, L. F. (2017) · Seminars in Cutaneous Medicine and Surgery · doi:10.12788/j.sder.2017.035 · Cited by 15
Management of Atopic Hand Dermatitis
Halling, A., Zachariae, C. O. C., & Thyssen, J. P. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.02.010 · Cited by 15
Rikken, G., van den Brink, N. J. M., van Vlijmen‐Willems, I. M. J. J., van Erp, P. E. J., Pettersson, L., Smits, J. P. H., & van den Bogaard, E. H. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031773 · Cited by 14
Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis
Furue, M., Kadono, T., Tsuji, G., & Nakahara, T. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1397626 · Cited by 14
T helper type 2 signatures in atopic dermatitis
Furue, M. (2018) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12023 · Cited by 14
Lead optimization of aryl hydrocarbon receptor ligands for treatment of inflammatory skin disorders
Rikken, G., Smith, K. J., van den Brink, N. J. M., Smits, J. P. H., Gowda, K., Alnemri, A. E., Kuzu, G. E., Murray, I. A., Lin, J.-M., Smits, J. G. A., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115400 · Cited by 14
Manuka honey activates the aryl hydrocarbon receptor: Implications for skin inflammation
Alangari, A., Ashoori, M. D., Alwan, W., Dawe, H. R., Stockinger, B., Barker, J. N., Wincent, E., & Meglio, P. D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106848 · Cited by 13
Protective role of Galectin‐7 for skin barrier impairment in atopic dermatitis
Umayahara, T., Shimauchi, T., Iwasaki, M., Sakabe, J., Aoshima, M., Nakazawa, S., Yatagai, T., Yamaguchi, H., Phadungsaksawasdi, P., Kurihara, K., et al. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13672 · Cited by 13
Li, Z., Zhong, W., Hu, H. H., Chen, X., Zhang, W., Huang, H., Yu, B., & Dou, X. (2018) · Clinical and Experimental Dermatology · doi:10.1111/ced.13841 · Cited by 13
A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis
Na, C. H., Baghoomian, W., & Simpson, E. L. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3515 · Cited by 13
Elson, D. J., Nguyen, B. D., Bernales, S., Chakravarty, S., Jang, H. S., Korjeff, N. A., Zhang, Y., Wilferd, S. F., Castro, D. J., Plaisier, C. L., et al. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00253 · Cited by 12
Dai, X., Mizukami, Y., Watanabe, K., Tsuda, T., Shidahara, M., Yoshida, S., Yatsuzuka, K., Shiraishi, K., Mori, H., Murakami, M., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.08.038 · Cited by 12
Kim, D. Y., Won, K., Hwang, D. I., Lee, S. Y., Choi, I.-H., Kim, B., & Lee, H. M. (2022) · Horticulture Environment and Biotechnology · doi:10.1007/s13580-021-00393-4 · Cited by 12
Updated view of tars for psoriasis: what have we learned over the last decade?
Ávalos‐Viveros, M., García, R. E., Garcı̀a-Pèrez, M., Torres-Garcia, E., Bartolomé‐Camacho, M. C., Santes, V. F., & García‐Pérez, M. (2022) · International Journal of Dermatology · doi:10.1111/ijd.16193 · Cited by 12
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins
Niehues, H., Rikken, G., Kersten, F. F. J., Eeftens, J. M., van Vlijmen‐Willems, I. M. J. J., Rodijk‐Olthuis, D., Jansen, P. A. M., Hendriks, W. J. A. J., Ederveen, T. H. A., Schalkwijk, J., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.01.022 · Cited by 12
Self-citationPilot Studies on Two Complementary Bath Products for Atopic Dermatitis Children: Pine-Tar and Tea
Hon, K. E., Ng, W., Kung, J. S. C., Leung, P., & Leung, T. F. (2019) · Medicines · doi:10.3390/medicines6010008 · Cited by 12
Revival of AHR Agonist for the Treatment of Atopic Dermatitis: Tapinarof
Furue, M., & Nakahara, T. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00259-7 · Cited by 12
Old King Coal - molecular mechanisms underlying an ancient treatment for atopic eczema.
Irvine, A. D. (2013) · Arrow@dit (Dublin Institute of Technology) · Cited by 12
The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis
Lin, X., Meng, X., & Lin, J. (2024) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754241239050 · Cited by 11
Smith, K. J., Murray, I. A., Boyer, J. A., & Perdew, G. H. (2017) · Toxicology · doi:10.1016/j.tox.2017.11.020 · Cited by 11
Han, Y., Zhang, Y., Jin, M., Jin, Y.-H., Qiu, M., Li, W.-L., He, C., Yu, L., Hyun, J. W., Lee, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.047 · Cited by 11
Terminal keratinocyte differentiation in vitro is associated with a stable DNA methylome
Smits, J. P. H., Dirks, R. A. M., Qu, J., Oortveld, M. A. W., Brinkman, A. B., Zeeuwen, P. L. J. M., Schalkwijk, J., Zhou, H., Marks, H., & van den Bogaard, E. H. J. (2020) · Experimental Dermatology · doi:10.1111/exd.14153 · Cited by 11
Self-citationCardinali, G., Flori, E., Mastrofrancesco, A., Mosca, S., Ottaviani, M., Dell’Anna, M. L., Truglio, M., Vento, A., Zaccarini, M., Zouboulis, C. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147501 · Cited by 11
Mukherjee, N., Sutter, T. R., Arshad, S. H., Holloway, J. W., Zhang, H., & Karmaus, W. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13294 · Cited by 11
CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders
Arnold, K. A., Moran, M. C., Shi, H., van Vlijmen‐Willems, I. M. J. J., Rodijk‐Olthuis, D., Smits, J. P. H., & Brewer, M. G. (2024) · Experimental Dermatology · doi:10.1111/exd.15084 · Cited by 12
Lai, X., Huang, J., Li, Y., & Dong, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649857 · Cited by 12
The role of the skin microbiota in the modulation of cutaneous inflammation—Lessons from the gut
Elias, A., McBain, A. J., & O’Neill, C. A. (2021) · Experimental Dermatology · doi:10.1111/exd.14420 · Cited by 10
Berth‐Jones, J. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0018 · Cited by 10
Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates
Nong, Y. (2024) · Cutis · doi:10.12788/cutis.0949 · Cited by 10
Merk, H. F. (2019) · Der Hautarzt · doi:10.1007/s00105-019-04503-3 · Cited by 10
Yang, Y., & Chan, W. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116097 · Cited by 9
Fink, S., Sethmann, A., Hipler, U., & Wiegand, C. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106152 · Cited by 9
Dickel, H., Bauer, A., Brehler, R., Mahler, V., Merk, H. F., Neustädter, I., Strömer, K., Werfel, T., Worm, M., & Geier, J. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14734_g · Cited by 9
Jia, Q., Liu, P., Wang, X., Hu, J., Jia, J., Zhang, J., & Li, H. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03268-7 · Cited by 8
de Juan, A., Tabtim-On, D., Coillard, A., Becher, B., Goudot, C., & Segura, É. (2024) · Science Signaling · doi:10.1126/scisignal.adn6324 · Cited by 8
Atopic Dermatitis and Type 2 Immune Deviation
Furue, M., Ulzii, D., Vu, Y. H., Tsuji, G., Kido‐Nakahara, M., & Nakahara, T. (2019) · Current Treatment Options in Allergy · doi:10.1007/s40521-019-00219-w · Cited by 9
Benzo[a]pyrene aggravates atopic dermatitis-like skin lesions in mice
Yanagisawa, R., Koike, E., & Takano, H. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211036123 · Cited by 8
Resolving Inflammation by Targeting an Ancient Innate Immune Sensor with a Bacterial Metabolite
Johnston, A. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.815 · Cited by 8
Skin Rejuvenation in Aged Mice by Fecal Transplantation Microbiota from Young Mice Feces
Yu, S., Li, Z., Zhang, X., Zhang, Q., Zhang, L., Zhao, L., Liu, P., Guo, J., Chen, J., Zhang, C., et al. (2024) · Engineering · doi:10.1016/j.eng.2024.08.005 · Cited by 7
Atopic dermatitis-related anti-inflammatory in vitro effects of a plant extract mixture
Heinemann, N., Rademacher, F., Vollert, H., Gläser, R., & Harder, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-09053-4 · Cited by 7
Lee, J., Choi, H., Shin, H. S., & Kim, G.-D. (2024) · Molecules · doi:10.3390/molecules29245951 · Cited by 7
Beneficial effects of an alkaline topical treatment in patients with mild atopic dermatitis
Jureček, Ľ., Rajcigelova, T., Kozárová, A., Werner, T., Vormann, J., & Kolísek, M. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13936 · Cited by 7
Sharma, M., Sharma, G., Singh, B., Dhiman, V., Bhadada, S. K., & Katare, O. P. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1723545 · Cited by 7
Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update
Ch’en, P. Y., & Lio, P. (2024) · Dermatitis · doi:10.1089/derm.2023.0373 · Cited by 6
Pérez‐Diego, M., Angelina, A., Pat, Y., Maldonado, A. E., Sevilla‐Ortega, C., Martín‐Cruz, L., Yazıcı, D., Rückert, B., Sokołowska, M., Martín‐Fontecha, M., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.05.002 · Cited by 6
Phelan, S. J., Palmer, B. C., Chen, Y., & DeLouise, L. A. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa091 · Cited by 6
Adjunctive Management of Itch in Atopic Dermatitis
Brooks, S. G., & Yosipovitch, G. (2024) · Dermatologic Clinics · doi:10.1016/j.det.2024.04.008 · Cited by 6
The Antioxidant PAPLAL Protects against Allergic Contact Dermatitis in Experimental Models
Shibuya, S., Watanabe, K., & Shimizu, T. (2024) · Antioxidants · doi:10.3390/antiox13060748 · Cited by 6
Zhang, W., Sakai, T., Matsuda‐Hirose, H., Goto, M., Yamate, T., & Hatano, Y. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.07.008 · Cited by 6
Small-Molecule-Based Immunotherapy for Immunologically Mediated Skin Conditions
Sernicola, A., Russo, I., & Alaibac, M. (2020) · Immunotherapy · doi:10.2217/imt-2019-0190 · Cited by 6
Bouchard, K. V., & Costin, G. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1256399 · Cited by 6
Aryl Hydrocarbon Receptor Activation: From Coal to Dioxin
Cline, A. E., & Feldman, S. R. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2018.1466463 · Cited by 6
AhR Modulating Agent for the Topical Therapy of Plaque Psoriasis
Bieber, T. R. M. (2021) · New England Journal of Medicine · doi:10.1056/nejme2116301 · Cited by 6
Emerging Contaminants: An Important But Ignored Risk Factor for Psoriasis
Huang, L., Zhou, Y. Y., Xiao, H., Li, Y., Zhou, Z., Xiao, Z., Tong, Y., Hu, K., Kuang, Y., Shen, M., et al. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09043-4 · Cited by 5
Advancing dermatology with skin equivalents and organoids in pathophysiology and drug testing
Lakeh, B., & Shafiee, A. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.10.008 · Cited by 8
Current and emerging drugs for the treatment of pruritus: an update of the literature
Mahmoud, R. H., Brooks, S. G., & Yosipovitch, G. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2349193 · Cited by 5
Liu, Z., Jiang, X., Zhao, K., Ruan, H., Ma, Y., Ma, Y., Zhou, Q., Zhang, J., Sun, X., Ma, W., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1439367 · Cited by 6
Nguyen, P.-T., Nakamura, Y., Tran, N. Q. V., Ishimaru, K., Nguyen, T.-A., Kobayashi, Y., Watanabe-Saito, F., Okuda, T., Nakano, N., & Nakao, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129997 · Cited by 5
Novel Topical Treatments for Itch
Mahmoud, R. H., Mahmoud, O., Soares, G. B., & Yosipovitch, G. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01144-w · Cited by 5
He, S., Wang, Z., Wang, R., Chi, B., Wang, Y., Bu, L., Wu, J., Li, H., & Huang, Q. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105722 · Cited by 5
Polycyclic aromatic hydrocarbons exposure associated with increased risk of psoriasis
Shu, Z., Lei, L., Jiang, L., Fu, C., Wen, Y., Huang, J., Zhang, K., Huang, J., Chen, J., & Zeng, Q. (2024) · Experimental Dermatology · doi:10.1111/exd.15166 · Cited by 6
AHR in the skin: From the mediator of chloracne to a therapeutic panacea?
Merches, K., Haarmann‐Stemmann, T., Weighardt, H., Krutmann, J., & Esser, C. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.02.002 · Cited by 5
Epigenetics of Allergic Diseases Allergies, Eczema, Asthma, and Rhinitis
Karmaus, W., Ziyab, A. H., & Mukherjee, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00019-4 · Cited by 5
Esser, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041844 · Cited by 5
New topical therapies for psoriasis
Buechler, C. R., Veenstra, J. J., & Gold, L. S. (2021) · Dermatological Reviews · doi:10.1002/der2.84 · Cited by 5
The aryl hydrocarbon receptor pathway plays a central role in the cutaneous response to pollutants
Guillon, C., Meziani, M., Abdelli, S., Sigaudo‐Roussel, D., Bonod‐Bidaud, C., & Nosbaum, A. (2022) · European Journal of Dermatology · doi:10.1684/ejd.2022.4262 · Cited by 5
“Tar smarts” may have a new meaning for atopic dermatitis and psoriasis
Heymann, W. R. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.10.057 · Cited by 5
Yang, J., Qiao, P., Wang, G., & Dang, E. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70047 · Cited by 8
Fukasawa, T., Yamashita, T., Enomoto, A., Yoshizaki‐Ogawa, A., Miyagawa, K., Sato, S., & Yoshizaki, A. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19499 · Cited by 4
Urashima, T., Katsuda, Y., Yoshiuchi, H., Ebihara, S., Shinozaki, Y., Kato, T., Shimazaki, T., Yasui, Y., Mera, Y., & Konishi, N. (2024) · BPB Reports · doi:10.1248/bpbreports.7.4_123 · Cited by 4
The role of the aromatic hydrocarbon receptor in the pathogenesis of atopic dermatitis
Gorodnichev, P. V. (2023) · Vestnik dermatologii i venerologii · doi:10.25208/vdv4775 · Cited by 4
Microbiome in Atopic Dermatitis: Is It All About Staphylococcus aureus?
Gómez‐Casado, C., Unger, Z., Oláh, P., & Homey, B. (2023) · Current Treatment Options in Allergy · doi:10.1007/s40521-023-00350-9 · Cited by 4
Hu, Y., Zhao, Y., & Zhang, J. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s430915 · Cited by 4
Buckley, D. A. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook018 · Cited by 4
The skin commensal yeast Malassezia promotes tissue homeostasis via the aryl hydrocarbon receptorPreprint
Ibáñez, E., Stokmaier, M., Barone, G., Staropoli, A., Karakaya, T., Beer, H., Vinale, F., Ianiri, G., & LeibundGut‐Landmann, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.26.645515 · Cited by 4
Tapinarof in atopic dermatitis: A comprehensive scoping review of clinical efficacy and safety
Fardos, M. I., Cheedalla, N., Watson, A. R., & Esguerra, D. (2024) · JAAD reviews. · doi:10.1016/j.jdrv.2024.12.001 · Cited by 3
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
Spencer, R. K., Jin, J. Q., Elhage, K. G., Davis, M. S., Liao, W. J., & Bhutani, T. (2023) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s393997 · Cited by 3
Alqam, M. L., Jones, B. C., & Hitchcock, T. M. (2023) · PubMed Central · Cited by 3
Topical treatments for eczema: a network meta-analysis
Yew, Y. W., Zheng, Q., Kok, W. L., Ho, M. S. L., Teoh, J. Y., Wong, Y., Shi, L., & Chan, E. S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013205 · Cited by 3
RetractedJustiniano, R., & Wondrak, G. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-43157-4_16 · Cited by 3
Kang, Y., Lee, M., & An, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797086 · Cited by 3
Metadata
- Authors
- van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J.
- Affiliations
- Radboud University Medical Center (NL)
- University Hospital Schleswig-Holstein (DE)
- Radboud University Nijmegen (NL)
- Venue
- Journal of Clinical Investigation
- Published
- 2013-01-25
- Volume
- 123
- Issue
- 2
- Pages
- 917-27
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3561798
- OpenAlex
- W2047893094
- Cited by
- 373
- References
- 64
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 36 · 2023: 31 · 2022: 38 · 2021: 33 · 2020: 34 · 2019: 25 · 2018: 33 · 2017: 30 · 2016: 18 · 2015: 19 · 2014: 28 · 2013: 12
- FWCI
- 30.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- coal tar, atopic dermatitis, aryl hydrocarbon receptor, skin barrier repair, filaggrin, Th2 cytokines, IL-4, IL-13, Nrf2 signaling, epidermal differentiation, keratinocytes, spongiosis, CCL26, organotypic skin model
- MeSH terms
- Filaggrin Proteins, Administration, Topical, Cell Differentiation, Cells, Cultured, Coal Tar, Dermatitis, Atopic, Humans, Intermediate Filament Proteins, Models, Biological, Signal Transduction, Keratinocytes, Up-Regulation, Cytokines, Receptors, Aryl Hydrocarbon, Oxidative Stress, Th2 Cells, RNA, Small Interfering, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review